Anti-TNF therapy and the spondyloarthritides: who should be treated?
Braun, J.; Sieper, J.
Clinical and Experimental Rheumatology 20(6 Suppl 28: S187
2002
ISSN/ISBN: 0392-856X PMID: 12463475 Document Number: 545597
Document emailed within 1 workday
Related Documents
Babić-Naglić, D.; Grazio, S.; Anić, B.; Cikes, N.; Novak, S.; Morović-Vergles, J.; Kehler, T.; Marasović-Krstulović, D.; Milanović, S.; Hanih, M.; Perić, P.; Vlako, T.; Potocki, K.; Curković, B. 2013: The proposal of Croatian Society for Rheumatology for anti-TNF-alpha therapy in adult patients with spondyloarthritides, 2013 Reumatizam 60(1): 52-56Braun, J.; van der Heijde, D.; Pincus, T. 2002: Novel anti-rheumatic therapies challenge old views on ankylosing spondylitis and other spondyloarthritides Clinical and Experimental Rheumatology 20(6 Suppl 28: S1-S2
De Giorgio, F.; Abbate, A.; Capelli, A.; Arena, V. 2005: Spontaneous rupture of coronary artery in human immunodeficiency virus-positive patient treated with highly active anti-retroviral therapy (HAART) American Journal of Forensic Medicine and Pathology 26(2): 197
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Matsuda, J.; Saitoh, N.; Gotoh, M.; Gohchi, K.; Tsukamoto, M.; Syoji, S.; Miyake, K.; Yamanaka, M. 1995: High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha American Journal of Gastroenterology 90(7): 1138-1141
Anić, B.; Cerovec, M. 2011: Etiology and pathogenesis of spondyloarthritides Reumatizam 58(2): 36-38
Borges, N.E.; Desai, H.R.; Joshi, A.D.; Siqueira, R.D.; Mangat; Joshi, V.R. 1986: Unclassifiable seronegative spondyloarthritides Journal of the Association of Physicians of India 34(5): 387
Papagoras, C.; Voulgari, P.V.; Drosos, A.A. 2013: Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis Clinical and Experimental Rheumatology 31(4): 612-620
Ginestes, J. 1981: Anti-arrhythmic and anti-anginal properties of amiodarone in ambulatory therapy Annales de Cardiologie et d'Angeiologie 30(7): 529-533
Vuist, W.M.; v Buitenen, F.; de Rie, M.A.; Hekman, A.; Rümke, P.; Melief, C.J. 1989: Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation model Cancer Research 49(14): 3783-3788
De Arcangelis, A. 1971: On the use in anti-rheumatic therapy of a new non-steroid anti-inflammatory agent: glucosamide of monohydrated (N-p-chloro-benzoyl-2-methyl-5-methoxy)-indol-3-acetic acid La Clinica Terapeutica 59(3): 229-239
Kano, S. 1999: Serological diagnosis of streptococcal infection (anti-streptolysin O; ASO, anti-streptokinase; ASK, anti-deoxyribonuclease B; ADNB, anti-hyaluronidase; AHD, anti-streptococcal polysaccharide; ASP) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 107-116
Villarroya, F.; Domingo, P.; Giralt, M. 2005: Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity Trends in Pharmacological Sciences 26(2): 88-93
Materson, B.J.; Reda, D.J.; Cushman, W.C.; Henderson, W.G. 1995: Results of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents Journal of human hypertension 9(10): 791-796
Zhou, Z.; Dai, C.; Liu, W-Xin. 2015: Anti-TNF-A therapy about infliximab and adalimamab for the effectiveness in ulcerative colitis compared with conventional therapy: a meta-analysis Hepato-Gastroenterology 62(138): 309-318
Miyamoto, K.; Mitsui, M.; Katashio, H.; Wake, K.; Imataka, G.; Yamnouchi, H.; Eguchi, M. 2006: Case of theophylline-induced seizures successfully treated with mild hypothermic therapy and methylpredonisolone pulse therapy No to Hattatsu 38(3): 219-220
Fera, M.S.; Carunchio, A.; Burattini, M.; Mazza, A.; Coletta, C.; Galati, A.; Ceci, V. 1997: Comparison of anti-arrhythmic therapy guided by the transesophageal electropharmacologic test and emperic therapy in the prophylaxis of atrial fibrillation recurrence Giornale Italiano di Cardiologia 27(2): 152-163
Manthous, C.A.; Schmidt, G.A.; Kemp, R.; Wood, L.D. 1992: Fulminant hepatic failure treated with anti-endotoxin antibody Critical Care Medicine 20(11): 1617-1619
Sawada, Y.; Fujii, T.; Takahashi, H.; Yokoyama, G.; Matsubayashi, R.N.; Inoue, Y.; Uesugi, N.; Momosaki, S.; Toh, U.; Shirouzu, K. 2009: A case of triple negative chest wall recurrent breast cancer treated with capecitabine and docetaxel combination therapy (XT therapy) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 815-817
Duprey, J.; Izembart, M.; Vallée, G.; Goupil, M. 1986: Prognostic value of anti-TSH receptor antibodies in Basedow's disease treated with carbimazole Annales de Medecine Interne 137(7): 555-558